Aloe-emodin decreased the expression of β-catenin and the target genes cyclin D1 and c-Myc, causing pro-oxidant effects and elevated ROS, and it thus inhibited the growth of androgen-independent DU145 prostate cancer cells. The gene discussed is MYC; the disease is Familial prostate cancer.